EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Efficacy and safety of ranibizumab biosimilars for neovascular age-related macular degeneration: A comprehensive systematic review and meta-analysis

Anas Alamoudi, Ahmed Alnabihi, Naif Almufarriji, Abdullah S AlQahtani

AJO International · 2026-07 · 3 (2) · 100255

DOI: 10.1016/j.ajoint.2026.100255 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift AJO International, 2026-07. Verfasst von Anas Alamoudi und 3 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Alamoudi, A., Alnabihi, A., Almufarriji, N., & AlQahtani, A. S. (2026). Efficacy and safety of ranibizumab biosimilars for neovascular age-related macular degeneration: A comprehensive systematic review and meta-analysis. AJO International, 3(2), 100255. https://doi.org/10.1016/j.ajoint.2026.100255

Vancouver

Alamoudi A, Alnabihi A, Almufarriji N, AlQahtani AS. Efficacy and safety of ranibizumab biosimilars for neovascular age-related macular degeneration: A comprehensive systematic review and meta-analysis. AJO International. 2026;3(2):100255. doi:10.1016/j.ajoint.2026.100255

BibTeX
@article{Alamoudi2026,
  author = {Alamoudi, Anas and Alnabihi, Ahmed and Almufarriji, Naif and AlQahtani, Abdullah S},
  title = {Efficacy and safety of ranibizumab biosimilars for neovascular age-related macular degeneration: A comprehensive systematic review and meta-analysis},
  journal = {AJO International},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {100255},
  doi = {10.1016/j.ajoint.2026.100255}
}
Kostenlos starten →